ID Source | ID |
---|---|
PubMed CID | 99855 |
CHEMBL ID | 3249829 |
SCHEMBL ID | 1395878 |
MeSH ID | M0040408 |
Synonym |
---|
35319-96-1 |
nsc240869 |
nsc-240869 |
2-bromo-3-(1h-imidazol-5-yl)propanoic acid |
2-bromo-3-(1h-imidazol-4-yl)propanoic acid |
dl-alpha-bromo-beta-(5-imidazoyl)propionic acid |
alpha-bromo-beta-(5-imidazolyl)propionic acid |
1h-imidazole-4-propanoic acid, alpha-bromo-, (+-)- |
d,l-alpha-bromo-beta-(5-imidazolyl)propionic acid |
nsc 240869 |
2-bromo-3-(5-imidazolyl)propionate |
dl-alpha-bromo-beta-(5-imidazolyl)propionic acid |
CHEMBL3249829 |
CRTWOYOCILXSSX-UHFFFAOYSA-N |
alpha-bromo-beta-(5-imidazolyl) propionic acid |
SCHEMBL1395878 |
dl-alpha-bromo-(5-imidazolyl)propionic acid |
dl-a-bromo-ss-(5-imidazolyl)propionic acid |
(r,s)-2-bromo-3-(5-imidazolyl)propionic acid |
FT-0765604 |
dl-alpha-bromo-beta-(5-imidazolyl)propionicacid |
SB46580 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1133933 | Inhibition of histidine decarboxylase in Sprague-Dawley rat stomach assessed as decrease in 14CO2 production using L-histidine-carboxyl-14C as substrate at 0.10 mM by scintillation counting analysis | 1977 | Journal of medicinal chemistry, Apr, Volume: 20, Issue:4 | Inhibition of histidine decarboxylase. Derivatives of histidine. |
AID1135700 | Inhibition of Rana catesbeiana tadpole collagenase using lathyritic rat skin collagen as substrate after 41 hrs by radial diffusion assay | 1978 | Journal of medicinal chemistry, Jul, Volume: 21, Issue:7 | Mercaptoimidazolylpropionic acid hydrobromide. Inhibition of tadpole collagenase and related properties. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 9 (64.29) | 18.7374 |
1990's | 5 (35.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |